title: Complete remission with a combination of lenalidomide, cyclophosphamide and prednisolone in a patient with incomplete POEMS syndrome.
authors.affiliation: Department of Hematology, Gazi University Faculty of Medicine, Ankara, Turkey. elifsuyani@hotmail.com
authors.forename: Elif
authors.initials: E
authors.lastname: Suyanı
authors.forename: Münci
authors.initials: M
authors.lastname: Yağcı
authors.forename: Gülsan Türköz
authors.initials: GT
authors.lastname: Sucak
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D020233:Gait Disorders, Neurologic / Q000209:etiology; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006227:Hand Deformities, Acquired / Q000209:etiology; D006801:Humans; D000077269:Lenalidomide; D016878:POEMS Syndrome / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D061988:Proteasome Inhibitors; D012074:Remission Induction; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D042442:Vascular Endothelial Growth Factors / Q000037:antagonists & inhibitors*
chemical_list: D000970:Antineoplastic Agents; D005938:Glucocorticoids; D061988:Proteasome Inhibitors; D042442:Vascular Endothelial Growth Factors; D013792:Thalidomide; D003520:Cyclophosphamide; D011239:Prednisolone; D000077269:Lenalidomide